Integrum AB (OSTO:INTEG B) Beneish M-Score: -2.42 (As of Jun. 30, 2026)


OSTO:INTEG B Integrum AB OSTO:INTEG B
57 GF Score
Price kr8.40
GF Value kr17.76
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Integrum AB Beneish M-Score?

Integrum AB OSTO:INTEG B +3.58% 57 Beneish M-Score is -2.42 as of Jun. 30, 2026. GuruFocus rates OSTO:INTEG B with a GF Score™ of 57/100 and a GF Value™ of kr17.76 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 765 Medical Devices & Instruments companies, Integrum AB ranks worse than 63.14% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.42 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Integrum AB's Beneish M-Score or its related term are showing as below:

OSTO:INTEG B' s Beneish M-Score Range Over the Past 10 Years
Min: -2.6   Med: -1.73   Max: 0.31
Current: -2.42

During the past 12 years, the highest Beneish M-Score of Integrum AB was 0.31. The lowest was -2.60. And the median was -1.73.


Integrum AB Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Integrum AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB Beneish M-Score Chart

Integrum AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 -1.60 -1.50 -2.48 -2.42

Integrum AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.48 0.00 0.00 0.00 -2.42

OSTO:INTEG B vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Integrum AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrum AB Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Integrum AB's Beneish M-Score falls into.


OSTO:INTEG B
57GF Score
Integrum AB OSTO:INTEG B
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrum AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Integrum AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1134+0.528 * 1.196+0.404 * 1.1374+0.892 * 1.0031+0.115 * 0.9952
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.026095-0.327 * 1.2405
=-2.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Apr26) TTM:Last Year (Apr25) TTM:
Total Receivables was kr34.28 Mil.
Revenue was kr91.39 Mil.
Gross Profit was kr63.23 Mil.
Total Current Assets was kr83.68 Mil.
Total Assets was kr203.60 Mil.
Property, Plant and Equipment(Net PPE) was kr9.32 Mil.
Depreciation, Depletion and Amortization(DDA) was kr11.90 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.00 Mil.
Total Current Liabilities was kr30.20 Mil.
Long-Term Debt & Capital Lease Obligation was kr1.40 Mil.
Net Income was kr-46.34 Mil.
Gross Profit was kr0.00 Mil.
Cash Flow from Operations was kr-41.02 Mil.
Total Receivables was kr30.69 Mil.
Revenue was kr91.10 Mil.
Gross Profit was kr75.38 Mil.
Total Current Assets was kr100.90 Mil.
Total Assets was kr203.06 Mil.
Property, Plant and Equipment(Net PPE) was kr5.18 Mil.
Depreciation, Depletion and Amortization(DDA) was kr6.54 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.00 Mil.
Total Current Liabilities was kr22.23 Mil.
Long-Term Debt & Capital Lease Obligation was kr3.17 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(34.275 / 91.385) / (30.688 / 91.1)
=0.375062 / 0.336861
=1.1134

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(75.382 / 91.1) / (63.226 / 91.385)
=0.827464 / 0.691864
=1.196

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (83.683 + 9.319) / 203.601) / (1 - (100.903 + 5.179) / 203.063)
=0.543214 / 0.477591
=1.1374

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=91.385 / 91.1
=1.0031

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(6.541 / (6.541 + 5.179)) / (11.898 / (11.898 + 9.319))
=0.558106 / 0.560777
=0.9952

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 91.385) / (0 / 91.1)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.398 + 30.196) / 203.601) / ((3.171 + 22.231) / 203.063)
=0.155176 / 0.125094
=1.2405

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-46.337 - 0 - -41.024) / 203.601
=-0.026095

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Integrum AB has a M-score of -2.42 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.42 mean?
Integrum AB (OSTO:INTEG B) has a Beneish M-Score of -2.42 as of Jun. 30, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Integrum AB and its competitors. According to the industry distribution chart, Integrum AB ranks #483 out of 765 companies in the Medical Devices & Instruments industry, placing it in the top 63.1%.
Is Integrum AB's Beneish M-Score too high?
Integrum AB's current Beneish M-Score is -2.42. Based on the distribution chart, Integrum AB ranks #483 out of 765 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Integrum AB has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Integrum AB ranks #483 out of 765 companies for Beneish M-Score. This places Integrum AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Integrum AB and its competitors. Integrum AB's current Beneish M-Score is -2.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (OSTO:INTEG B) is currently considered Possible Value Trap. The stock's GF Value™ is kr17.76, compared to a current price of kr8.40 — trading 52.7% below its estimated fair value. The current Beneish M-Score is -2.42. Integrum AB's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Integrum AB (OSTO:INTEG B), the current Beneish M-Score is -2.42 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrum AB (OSTO:INTEG B) Overvalued in 2026?

Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued. The current stock price of kr8.40 is trading 52.7% below its estimated GF Value™ of kr17.76. GuruFocus considers Integrum AB to be Possible Value Trap.

Key valuation signals for OSTO:INTEG B:

  • Beneish M-Score: -2.42
  • GF Value™: kr17.76 vs. price of kr8.40 (52.7% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the OSTO:INTEG B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integrum AB Business Description

Other Exchanges 6Y1:Germany
Address Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
57GF Score

Get the complete analysis for OSTO:INTEG B

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.40
Price
kr17.76
GF Value